Silver Book Fact

Survival rates for colon cancer went from 41 percent to 63 percent between 1975 and 1995.

Lichtenberg, Frank R. The Expanding Pharmaceutical Arsenal in the War on Cancer. National Bureau of Economic Research. February 2004; Working Paper No. 10328. http://www.nber.org/papers/w10328

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
National Bureau of Economic Research
Publication Date
February 2004
Authors
Lichtenberg, Frank R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, researchers are currently working on 646 medicines for cancer. All are either in clinical trials or under FDA review. …  
  • FDA Cancer Approvals for Aug 2014 to July 2015
     
  • Surgical biopsy for lumps in the breast was found by one study to cost 2 1/2 to 3 times more than image-guided core-needle biopsy ($698 versus $243).  
  • Cancer Survival Rate Increasing  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in the pipeline would inhibit production of a protein that may interfere with the effectiveness of chemotherapy.